Li RL - Search Results

1

[Traditional Chinese and Western medicine in the treatment of 27 patients with malignant lymphoma].

Li YS, Zhang TD, Li CW, Zhao XL, Wei ZR, Tan W, Li RL, Ma YY. Li YS, et al. Among authors: li cw, li rl. Zhonghua Zhong Liu Za Zhi. 1988 Jan;10(1):61-2. Zhonghua Zhong Liu Za Zhi. 1988. PMID: 3416701 Chinese.

2

[Combination of surgery, radiotherapy and chemotherapy for rectal cancer--a 423 cases report].

Li RL. Li RL. Zhonghua Zhong Liu Za Zhi. 1992 May;14(3):213-5. Zhonghua Zhong Liu Za Zhi. 1992. PMID: 1327697 Clinical Trial. Chinese.

3

[Summary of second national symposium of Tripterygium wilfordii].

Li RL. Li RL. Zhong Xi Yi Jie He Za Zhi. 1991 Dec;11(12):758-60, 732. Zhong Xi Yi Jie He Za Zhi. 1991. PMID: 1687966 Chinese. No abstract available.

4

[Influence of changshouling on immune functions in atherosclerosis patients].

Li R. Li R. Zhong Xi Yi Jie He Za Zhi. 1987 Oct;7(10):594-5, 580. Zhong Xi Yi Jie He Za Zhi. 1987. PMID: 3447758 Chinese. No abstract available.

5

[Clinical and experimental study on sustained release tablet of Tripterygium wilfordii in treating rheumatoid arthritis].

Li RL, Liu PL, Wu XC. Li RL, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1996 Jan;16(1):10-3. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1996. PMID: 8732122 Clinical Trial. Chinese.

6

[The investigation and progress of the cellular and molecular biological mechanisms of Tripterygium wilfordii in treating rheumatoid arthritis].

Chen Z, Li RL, Tu SH. Chen Z, et al. Among authors: li rl. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Feb;29(2):183-6. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009. PMID: 19382484 Review. Chinese. No abstract available.

7

Association of neutrophil-to-lymphocyte ratio and risk of all-cause and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease: a population-based cohort study.

Zhang Y, Zhang AH, Li RL, Li WJ, Liu Y, Li T. Zhang Y, et al. Among authors: li rl. Front Med (Lausanne). 2024 Dec 10;11:1499524. doi: 10.3389/fmed.2024.1499524. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39722822 Free PMC article.

8

Molecular Additives as Competitive Binding Agents to Control Supramolecular-Driven Nanoparticle Assembly.

Li RL, Sbalbi N, Ye M, Macfarlane RJ. Li RL, et al. ACS Nanosci Au. 2024 Oct 31;4(6):374-380. doi: 10.1021/acsnanoscienceau.4c00062. eCollection 2024 Dec 18. ACS Nanosci Au. 2024. PMID: 39713727 Free PMC article.

9

Profiles of chemotherapy-induced peripheral neuropathy in breast cancer patients undergoing taxane-based chemotherapy: A latent class analysis.

Li RL, Bai LX, Liu Y, Yang AL, Chen L, Zhao FY, Zhang L, Liu JE. Li RL, et al. Eur J Oncol Nurs. 2024 Dec 7;74:102758. doi: 10.1016/j.ejon.2024.102758. Online ahead of print. Eur J Oncol Nurs. 2024. PMID: 39671956

10

Striding beyond numbness: a non-randomized controlled study of an exercise program for breast cancer patients with chemotherapy-induced peripheral neuropathy.

Li RL, Liu JE, Bai LX, Yang AL, Liu Y, Zhao FY, Chen L, Liu J. Li RL, et al. Support Care Cancer. 2024 Nov 29;32(12):837. doi: 10.1007/s00520-024-09003-2. Support Care Cancer. 2024. PMID: 39611862 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters